Evidence map›Paper›PMID 40391205›Full record

ArticleJOR spine2025

In Vitro Validation of Pulsed Electromagnetic Field (PEMF) as an Effective Countermeasure Against Inflammatory-Mediated Intervertebral Disc Degeneration.

Laura Guarnaccia, Laura Begani, Silvana Pileggi, Mauro Pluderi, Stefano Borsa, Claudia Fanizzi, Massimiliano Domenico Rizzaro, Giorgio Fiore, Laura Fontana, Rolando Campanella and 11 more

Abstract read
In one paragraph

Article in JOR spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Laura GuarnacciaCenter of Aerospace Medicine for Advanced Therapies (CeMATA), Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit Foundation IRCCS ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Laura BeganiCenter of Aerospace Medicine for Advanced Therapies (CeMATA), Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit Foundation IRCCS ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Silvana PileggiAndremacon Srl Milan Italy.
Mauro PluderiNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Stefano BorsaNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Claudia FanizziNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Massimiliano Domenico RizzaroNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Giorgio FioreNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Laura FontanaNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Rolando CampanellaAndremacon Srl Milan Italy.
Chiara CordiglieriIstituto Nazionale Genetica Molecolare Romeo Ed Enrica Invernizzi Milan Italy.
Chiara GaudinoDepartment of Neuroradiology Azienda Ospedaliero-Universitaria Policlinico Umberto I Rome Italy.
Giovanni A AlottaAndremacon Srl Milan Italy.
Monica MiozzoNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Emanuele GarziaAerospace Medicine Institute "A. Mosso" Italian Air Force Milan Italy.
Emanuela BarillaAndremacon Srl Milan Italy.
Lorenzo FassinaDepartment of Electrical, Computer and Biomedical Engineering University of Pavia Pavia Italy.
Laura RiboniAndremacon Srl Milan Italy.
Marco LocatelliNeurosurgery Unit Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
Giovanni MarfiaCenter of Aerospace Medicine for Advanced Therapies (CeMATA), Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit Foundation IRCCS ca' Granda Ospedale Maggiore Policlinico Milan Italy.ORCID https://orcid.org/0000-0002-5849-7000
Stefania E NavoneCenter of Aerospace Medicine for Advanced Therapies (CeMATA), Laboratory of Experimental Neurosurgery and Cell Therapy, Neurosurgery Unit Foundation IRCCS ca' Granda Ospedale Maggiore Policlinico Milan Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intervertebral disc (IVD) degeneration (IDD) is the main contributor to chronic low back pain (LBP), the leading cause of disability worldwide, with a significant impact on the quality of life and health of common people. The etiology of IDD is still unclear, but it has been largely demonstrated the crucial role of inflammation and neuroinflammation in the pathological and degenerative cascade of events characterizing IVD degeneration. Aim: In this study, we evaluated the potential therapeutic effect of pulsed electromagnetic field (PEMF) on human degenerated IVD (D-IVD) cells collected from patients who underwent discectomy. Materials & Methods: The experimental plan to test our hypothesis, involved viability assay, reactive oxide species/nitrite production, gene, and protein expression. To recapitulate the pro-inflammatory disc microenvironment occurring during IDD, interleukin-1β (IL-1β) was administered to IVD cell culture. Then, to dissect the contribution of neuroinflammatory condition to immune component, microglial cells were co-cultured with IVD-conditioned media, and viability and expression of inflammatory markers were detected. Results: Our data prove that in the IVD degenerative microenvironment, the increase of pro-inflammatory mediators, extracellular matrix degradative enzymes, and neuroinflammatory markers could be reduced by PEMF therapy, resulting in an overall improvement of degenerative condition and LBP. Conclusion: These results represent an impactful novelty for the management of people suffering from LPB, in terms of symptom relief and reduction of social-health system burden.

Indexed as

inflammationintervertebral disc degenerationmicrogliapilotspulsed electromagnetic fieldspace

Identifiers

PMID40391205
PMCPMC12086804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.